These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 14586389

  • 1. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
    Pauli-Magnus C, Feiner J, Brett C, Lin E, Kroetz DL.
    Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
    [Abstract] [Full Text] [Related]

  • 2. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang IJ, Shin SG.
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [Abstract] [Full Text] [Related]

  • 3. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
    Shon JH, Yoon YR, Hong WS, Nguyen PM, Lee SS, Choi YG, Cha IJ, Shin JG.
    Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
    [Abstract] [Full Text] [Related]

  • 4. Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects.
    Kim KA, Park PW, Park JY.
    Br J Clin Pharmacol; 2007 Jan; 63(1):53-8. PubMed ID: 16869811
    [Abstract] [Full Text] [Related]

  • 5. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.
    Johne A, Köpke K, Gerloff T, Mai I, Rietbrock S, Meisel C, Hoffmeyer S, Kerb R, Fromm MF, Brinkmann U, Eichelbaum M, Brockmöller J, Cascorbi I, Roots I.
    Clin Pharmacol Ther; 2002 Nov; 72(5):584-94. PubMed ID: 12426522
    [Abstract] [Full Text] [Related]

  • 6. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S, Yaren A, Kursunluoglu R, Turgut G.
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [Abstract] [Full Text] [Related]

  • 7. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
    Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Büchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P.
    Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
    [Abstract] [Full Text] [Related]

  • 8. Increased drug delivery to the brain by P-glycoprotein inhibition.
    Sadeque AJ, Wandel C, He H, Shah S, Wood AJ.
    Clin Pharmacol Ther; 2000 Sep; 68(3):231-7. PubMed ID: 11014404
    [Abstract] [Full Text] [Related]

  • 9. Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokinetics.
    Putnam WS, Woo JM, Huang Y, Benet LZ.
    J Clin Pharmacol; 2005 Apr; 45(4):411-21. PubMed ID: 15778422
    [Abstract] [Full Text] [Related]

  • 10. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
    Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B, Warzok R, Kroemer HK, Cascorbi I.
    Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
    [Abstract] [Full Text] [Related]

  • 11. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
    Droździk M, Białecka M, Myśliwiec K, Honczarenko K, Stankiewicz J, Sych Z.
    Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
    [Abstract] [Full Text] [Related]

  • 12. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.
    Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M.
    Gastroenterology; 2003 Jan; 124(1):26-33. PubMed ID: 12512026
    [Abstract] [Full Text] [Related]

  • 13. P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth.
    Drozdzik M, Mysliwiec K, Lewinska-Chelstowska M, Banach J, Drozdzik A, Grabarek J.
    J Clin Periodontol; 2004 Sep; 31(9):758-63. PubMed ID: 15312098
    [Abstract] [Full Text] [Related]

  • 14. Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study.
    Yasui-Furukori N, Saito M, Nakagami T, Kaneda A, Tateishi T, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):286-91. PubMed ID: 16386826
    [Abstract] [Full Text] [Related]

  • 15. Impact of P-glycoprotein on clopidogrel absorption.
    Taubert D, von Beckerath N, Grimberg G, Lazar A, Jung N, Goeser T, Kastrati A, Schömig A, Schömig E.
    Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805
    [Abstract] [Full Text] [Related]

  • 16. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
    Meisel P, Giebel J, Kunert-Keil C, Dazert P, Kroemer HK, Kocher T.
    Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
    [Abstract] [Full Text] [Related]

  • 17. Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans.
    Brunner M, Langer O, Sunder-Plassmann R, Dobrozemsky G, Müller U, Wadsak W, Krcal A, Karch R, Mannhalter C, Dudczak R, Kletter K, Steiner I, Baumgartner C, Müller M.
    Clin Pharmacol Ther; 2005 Aug; 78(2):182-90. PubMed ID: 16084852
    [Abstract] [Full Text] [Related]

  • 18. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F.
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [Abstract] [Full Text] [Related]

  • 19. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson EA, Brodie MJ.
    Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
    [Abstract] [Full Text] [Related]

  • 20. Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosis.
    Dilger K, Cascorbi I, Grünhage F, Hohenester S, Sauerbruch T, Beuers U.
    Liver Int; 2006 Apr; 26(3):285-90. PubMed ID: 16584389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.